Dr Arezina article published in GMP review

Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review ‘ The application of GMP and its role in maximising the benefits of adaptive study design in early phase clinical trials’

The full article can be read here.

Testimonials

I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.

- Anonymous

Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.

- Anonymous

Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.

- Anonymous

Latest news

COVID-19 – External Monitoring Guidelines

01st Jul 2020

Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing

Read more ›

Update on COVID-19

29th May 2020

Richmond Pharmacology update on SARS-CoV-2 infection control and management of clinical trials

Read more ›

Statement on COVID-19

23rd Mar 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are

Read more ›

On Helix, Transforming new medicine discovery

Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON

View event ›